Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rosso

Showing results (441-450 of 478) with videos related to

Pageof 48
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancerE Baldini, G Gardin, P G Giannessi, et al.
Tumori|January 16, 1998
A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, ItalyE Baldini, G Gardin, P Giannessi, et al.
British Journal of Cancer|June 3, 2004
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safetyE Baldini, T Prochilo, B Salvadori, et al.
Contact Dermatitis|May 2, 2000
Very delayed reactions to beta-lactam antibioticsR Rosso, G Mattiacci, M L Bernardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)P F Conte, E Baldini, G Gardin, et al.
British Journal of Cancer|February 14, 1998
Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II studyC Aschele, A Guglielmi, G L Frassineti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)L Del Mastro, F Perrone, L Repetto, et al.
Histopathology|November 26, 2003
Lymph node reticulum cell neoplasm with progression into cytokeratin-positive interstitial reticulum cell (CIRC) sarcoma: a case studyM Lucioni, E Boveri, R Rosso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicityM Venturini, G Lunardi, L Del Mastro, et al.
British Journal of Cancer|June 23, 2005
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patientsL Del Mastro, P Bruzzi, G Nicolò, et al.
Pageof 48

Showing results (441-450 of 478) with videos related to

Sort By:
Pageof 48
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancerE Baldini, G Gardin, P G Giannessi, et al.
Tumori|January 16, 1998
A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, ItalyE Baldini, G Gardin, P Giannessi, et al.
British Journal of Cancer|June 3, 2004
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safetyE Baldini, T Prochilo, B Salvadori, et al.
Contact Dermatitis|May 2, 2000
Very delayed reactions to beta-lactam antibioticsR Rosso, G Mattiacci, M L Bernardi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)P F Conte, E Baldini, G Gardin, et al.
British Journal of Cancer|February 14, 1998
Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II studyC Aschele, A Guglielmi, G L Frassineti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 26, 2005
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)L Del Mastro, F Perrone, L Repetto, et al.
Histopathology|November 26, 2003
Lymph node reticulum cell neoplasm with progression into cytokeratin-positive interstitial reticulum cell (CIRC) sarcoma: a case studyM Lucioni, E Boveri, R Rosso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicityM Venturini, G Lunardi, L Del Mastro, et al.
British Journal of Cancer|June 23, 2005
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patientsL Del Mastro, P Bruzzi, G Nicolò, et al.
Pageof 48